The relationship between automatic thoughts and depression in a cognitive-behavioral treatment for people living with HIV/AIDS: Exploring temporality and causality.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28989210)

Published in Cognit Ther Res on March 01, 2017

Authors

Kristen E Riley1, Jasper S Lee2, Steven A Safren2,3

Author Affiliations

1: Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY.
2: Department of Psychology, University of Miami, Coral Gables, FL.
3: The Fenway Institute, Boston, MA.

Articles cited by this

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry (1998) 65.11

A new depression scale designed to be sensitive to change. Br J Psychiatry (1979) 36.40

Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet (2007) 15.96

Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med (2000) 12.83

Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry (2001) 7.30

Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry (2001) 5.22

Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care (2008) 4.33

Role of depression, stress, and trauma in HIV disease progression. Psychosom Med (2008) 3.65

Depression and HIV/AIDS treatment nonadherence: a review and meta-analysis. J Acquir Immune Defic Syndr (2011) 3.54

A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals. Health Psychol (2009) 3.26

Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment. Psychosom Med (2005) 2.83

Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients. J Acquir Immune Defic Syndr (2008) 2.35

Associations of depression, self-esteem, and substance use with sexual risk among adolescents. Prev Med (2001) 2.29

Underdiagnosis of depression in HIV: who are we missing? J Gen Intern Med (2003) 2.21

The newest epidemic: a review of HIV/AIDS in Central and Eastern Europe. Int J STD AIDS (2003) 2.12

Prevalence of DSM-IV-defined mood, anxiety, and substance use disorders in an HIV clinic in the Southeastern United States. J Acquir Immune Defic Syndr (2006) 2.01

Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: a randomized controlled trial. J Consult Clin Psychol (2012) 1.94

A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in patients with uncontrolled type 2 diabetes. Diabetes Care (2013) 1.81

The effect of mental illness, substance use, and treatment for depression on the initiation of highly active antiretroviral therapy among HIV-infected individuals. AIDS Patient Care STDS (2008) 1.68

A roadmap to rumination: a review of the definition, assessment, and conceptualization of this multifaceted construct. Clin Psychol Rev (2008) 1.54

Prevalence and predictors of depressive, anxiety and substance use disorders in HIV-infected and uninfected men: a longitudinal evaluation. Psychol Med (1997) 1.52

Natural history of neuropsychiatric manifestations of HIV disease. Psychiatr Clin North Am (1994) 1.43

Depression and HIV disease. J Assoc Nurses AIDS Care (2003) 1.43

Review of treatment studies of depression in HIV. Top HIV Med (2006) 1.30

Depression and adherence to antiretroviral therapy in low-, middle- and high-income countries: a systematic review and meta-analysis. Curr HIV/AIDS Rep (2014) 1.23

Challenges in addressing depression in HIV research: assessment, cultural context, and methods. AIDS Behav (2011) 1.22

Moderate levels of depression predict sexual transmission risk in HIV-infected MSM: a longitudinal analysis of data from six sites involved in a "prevention for positives" study. AIDS Behav (2013) 1.12

Cognitive change processes in a group cognitive behavior therapy of depression. J Behav Ther Exp Psychiatry (2003) 1.08

A preliminary RCT of CBT-AD for adherence and depression among HIV-positive Latinos on the U.S.-Mexico border: the Nuevo Día study. AIDS Behav (2013) 1.01

Cognitive-behavioral assessment of depression: clinical validation of the automatic thoughts questionnaire. J Consult Clin Psychol (1983) 0.94

Effective Treatment of Depressive Disorders in Medical Clinics for Adolescents and Young Adults Living With HIV: A Controlled Trial. J Acquir Immune Defic Syndr (2016) 0.78

Cognitive vulnerability for depression in HIV. J Affect Disord (2013) 0.78

Depression CBT treatment gains among HIV-infected persons with a history of injection drug use varies as a function of baseline substance use. Psychol Health Med (2015) 0.78

The six cycles maintenance model: Growing a "vicious flower" for depression. Behav Cogn Psychother (2009) 0.77

Measuring changes in negative and positive thinking in patients with depression. Perspect Psychiatr Care (2010) 0.76